[Clinical evaluation of the action of 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in coronary insufficiency].
D001161:Arteriosclerosis; D001713:Biphenyl Compounds; D006801:Humans; D006973:Hypertension; D009203:Myocardial Infarction; D011299:Prenylamine; D011437:Propylamines
D001713:Biphenyl Compounds; D011299:Prenylamine; D011437:Propylamines; C010574:biphenyl
ARTERIOSCLEROSIS; HYPERTENSION; MYOCARDIAL INFARCT; SEGONTIN